布地奈德雾化吸入在婴幼儿肺炎支原体感染致慢性咳嗽治疗中的应用

Application of Budesonide Aerosol Inhalation in the Treatment of Chronic Cough Caused by Mycoplasma Pneumoniae Infection in Infants

目的:探讨布地奈德雾化吸入在婴幼儿肺炎支原体感染致慢性咳嗽治疗中的应用。方法:选取在我院接受治疗的510例肺炎支原体感染致慢性咳嗽患儿,随机分为对照组(n=255)与观察组(n=255);两组患儿均对症治疗,对照组给予孟鲁司特治疗,观察组在此基础上加用布地奈德雾化吸入治疗,对比两种用药方法的效果。结果:观察组治疗整体有效率高于对照组(P<0.05),观察组症状开始缓解时间与症状消失时间均短于对照组(P<0.05)。结论:在婴幼儿肺炎支原体感染致慢性咳嗽的常规孟鲁司特治疗中引入布地奈德雾化吸入方案,能够提高临床治疗效果。

Objective:To explore the application of Budesonide aerosol inhalation in the treatment of chronic cough caused by Mycoplasma pneumoniae infection in infants.Methods:510 children with chronic cough caused by Mycoplasma pneumoniae infection were selected and randomly divided into control group(n=255)and observation group(n=255).Two groups of patients were treated symptomatically,while the control group was treated with montelukast.The observation group was treated with Budesonide aerosol inhalation on the basis of the control group,and the effect of the two medication methods was compared.Results:The overall effective rate of treatment in the observation group was higher than that in the control group(P<0.05),The time of symptom relief and disappearance in the observation group were shorter than those in the control group(P<0.05).Conclusion:Introducing Budesonide aerosol inhalation into routine montelukast therapy for chronic cough caused by Mycoplasma pneumoniae infection in infants can improve clinical treatment effect.